Blog

Evaluating Pregabalin for Chronic Cough in Lung Cancer

Non-Small Cell Lung Cancer/LinkedIn

Nov 30, 2024, 22:15

Evaluating Pregabalin for Chronic Cough in Lung Cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X:

“Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial.

Pregabalin does not significantly decrease cough in patients with lung cancer. Systemic cancer-directed therapy is the most effective antitussive.”

Pregabalin for chronic cough due to lung cancer: randomized, double-blind, placebo-controlled trial

Authors: Vanita Noronha, Nandini Menon, Vijay M. Patil, Minit Shah, Amit Joshi, Srushti Shah, Kavita Nawale, Rohan Surve, Gunj Bafna, Shweta Jogdhankar, Priyanka Shelar, Ankush Shetake, Ashish Singh, Sushmita Salian, Pundlik Jadhav, Hetakshi Shah, Neha Mer, Ananya Vohra, Swaratika Majumdar, Shripad Banavali, Rajendra Badwe & Kumar Prabhash

Evaluating Pregabalin for Chronic Cough in Lung Cancer

antitussive cancer cancer care Cancer research cancer survivorship cancer treatment cancer-directed therapy chronic cough double-blind trial health outcomes Lung cancer lung cancer patients lung cancer treatment medical oncology OncoDaily Oncology oncology research pharmacology placebo-controlled trial pregabalin randomized trial respiratory therapy systemic therapy Yakup Ergün

OncoThon 2024 Raises $1.3 Million for Pediatric Cancer Research

Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma

Richard Sullivan: The State of Global Cancer Surgery from Political and Equity Perspectives

Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More

Radiotherapy for Anus Cancer: Types, Success Rate, Side Effects And More

Special Coverage